Shared cancer neoantigens: Making private matters public.
Christopher A KlebanoffJedd D WolchokPublished in: The Journal of experimental medicine (2017)
In this issue of JEM, Chheda et al. (https://doi.org/10.1084/jem.20171046) report that a conserved hotspot mutation associated with an aggressive form of brain cancer generates an immunogenic T cell epitope restricted by a common HLA subtype, thereby creating a "public" neoantigen.